###### Comparison of occipitocervical fusion patient groups

  -------------------------------------------------------------------------------------------------
                            Revision                                       No revision      *p*
  ------------------------- ---------------------------------------------- ---------------- -------
  *N*                       11 (10%)                                       96 (89%)         −

  POCA                      Mean: 109.5\                                   Mean: 107.1\     0.23
                            Range: 72--123                                 Range: 85--141   

                            Revision (excluding infection as indication)   No revision      

  Adjacent level disease    2 (1.8%)                                                        

  Instrumentation failure   5 (4.7%)                                                        

  Total                     7 (6.5%)                                       94 (88%)         

  POCA (degrees)            Mean: 115\                                     Mean: 107.1\     0.039
                            Range: 80--136                                 Range: 85--141   
  -------------------------------------------------------------------------------------------------

*Note*: When patients who underwent revision surgery for reasons other than infection (adjacent segment degeneration or instrumentation failure), a significantly higher POCA (115 degrees, *n* = 0.039) was found.

This study has been approved by the institutional review board (IRB) of Thomas Jefferson University.
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